Doxazosin Mesylate Tablet
Product Images NDC 62135-052

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin Mesylate (NDC 62135-052). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Doxazosin Figure1)

Two line graphs depicting clinical study data related to Doxazosin mesylate treatment versus placebo. The first graph shows the mean change in total symptom score from baseline over 14 weeks, with Doxazosin mesylate group showing a greater decrease compared to placebo. The second graph shows the mean increase in maximum urinary flow rate (mL/sec) from baseline over 14 weeks, with the Doxazosin mesylate group displaying a higher increase than placebo. Both graphs indicate sample sizes of approximately 47-50 subjects per group.*

FDA Label Image

Doxazosin Tablets, Usp 1 mg (NDC 62135-051-90)

Doxazosin Tablets USP, 1 mg dosage strength, oral tablets. The label indicates 90 tablets per package. It is a prescription drug by Chartwell RX, LLC with instructions for storage and handling. The label features a barcode, NDC number 62135-051-90, and a patient information website link.*

FDA Label Image

Doxazosin Tablets, Usp 2 mg (NDC 62135-052-90)

Label for Doxazosin Tablets USP, 2 mg strength, oral dosage form. The label shows a blister pack containing 90 tablets, labeled for prescription use only. The labeler is Chartwell RX, LLC, with NDC 62135-052-90. The panel includes dosing and storage directions, a barcode, and patient information website.*

FDA Label Image

Doxazosin Tablets, Usp 4 mg (NDC 62135-053-90)

Label for Doxazosin Tablets, USP 4 mg, oral tablet form by Chartwell RX, LLC. The bottle contains 90 tablets. Label includes storage instructions, prescription-only status, and print patient information URL from Chartwell Pharmaceuticals. NDC 62135-053-90 is visible along with barcode and manufacturing details.*

FDA Label Image

Doxazosin Tablets, Usp 8 mg (NDC 62135-054-90)

Label for Doxazosin tablets, USP, 8 mg strength, containing 90 tablets. The label includes prescribing cautions, storage instructions, and manufacturer information for Chartwell RX, LLC. The package is marked Rx only with a NDC number 62135-054-90 and a barcode on the right.*

FDA Label Image

"image Description" (Doxazosin Structure)

Chemical structure of Doxazosin mesylate, depicting the molecular arrangement with methoxy groups, piperazine ring, and the mesylate group as part of the molecule.*

FDA Label Image

"image Description" (Doxazosin Table3)

A data table presenting results from two studies measuring change in symptom score and maximum flow rate (mL/sec) for Doxazosin mesylate tablets versus placebo. It includes baseline means, mean changes, and sample sizes across different dosage regimens (1 mg, 4 mg, 8 mg), showing numerical and graphical comparisons of efficacy endpoints related to symptom scores and urinary flow rates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.